Akoya Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	106	239	363	570	-	-
Market Cap Growth	-	-34.07%	-36.24%	-	-	-
Enterprise Value	129	241	358	489	18	3
PE Ratio	-3.39	-3.78	-5.14	-12.84	-	-
PS Ratio	1.13	2.48	4.85	10.37	-	-
PB Ratio	3.24	4.45	6.20	4.69	-	-
P/FCF Ratio	-4.14	-4.39	-5.97	-13.84	-	-
P/OCF Ratio	-4.44	-4.71	-6.79	-15.79	-	-
EV/Sales Ratio	1.38	2.50	4.78	8.91	0.42	0.07
EV/EBITDA Ratio	-5.09	-5.29	-6.08	-13.91	-1.78	-0.32
EV/EBIT Ratio	-4.32	-4.43	-5.42	-12.24	-1.29	-0.24
EV/FCF Ratio	-4.56	-4.42	-5.88	-11.89	-1.77	-0.19
Debt / Equity Ratio	2.60	1.59	1.29	0.27	-0.69	-0.82
Debt / EBITDA Ratio	-1.71	-1.88	-1.29	-0.94	-3.46	-2.57
Debt / FCF Ratio	-1.53	-1.57	-1.25	-0.80	-3.45	-1.49
Quick Ratio	2.28	2.85	2.46	4.44	1.37	1.65
Current Ratio	3.07	3.45	3.03	5.09	1.67	1.93
Asset Turnover	0.53	0.55	0.41	0.33	0.51	-
Interest Coverage	-6.29	-6.22	-14.48	-12.83	-5.12	-6.74
Return on Equity (ROE)	-123.40%	-110.20%	-85.30%	-51.20%	53.60%	-
Return on Assets (ROA)	-38.80%	-36.10%	-39.00%	-26.60%	-26.10%	-
Return on Capital (ROIC)	-51.08%	-40.17%	-49.27%	-24.13%	71.68%	249.70%
Earnings Yield	-64.05%	-26.44%	-19.45%	-7.79%	-	-
FCF Yield	-52.39%	-22.78%	-16.74%	-7.23%	-	-
Buyback Yield / Dilution	-28.34%	-17.72%	-40.34%	-1034.62%	-4.15%	-
Total Shareholder Return	-28.34%	-17.72%	-40.34%	-1034.62%	-4.15%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).